By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Enzo Biochem announced today that its Enzo Clinical Labs subsidiary has reached a deal to market a test based on IncellDx's HPV OncoTect technology.

HPV OncoTect will be validated in-house at Enzo Clinical labs, after which the company will seek approval in New York State to market the assay as a laboratory-developed test. If approved, Enzo would become the first New York licensed reference lab offering the test, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: variant linked to canine cleft lip, new compression tool, and more.

GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.

Fareed Zakaria writes that instead of focusing solely on STEM-related courses, students would do well to pursue the liberal arts if they want to be technology innovators.

A Harvard Business Review study found four major patterns of gender biases and added that black and Latina scientists further had to navigate racial stereotypes.